Lucy Scientific Discovery Inc. (LSDI)

0.8577 -0.0417 (-4.64%) As of 10:47AM EDT. Market open.

Lucy Scientific Discovery Inc.

1321 Blanshard Street
Suite 301
Victoria, BC V8W 0B6
Canada
778-410-5195
https://www.lucyscientific.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Richard D. Nanula	CEO & Executive Chair	41.66k	N/A	1961
Mr. Brian Zasitko C.A., CPA	Chief Financial Officer	100k	N/A	1981
Mr. Scott Michael Reeves L.L.B.	Corporate Secretary & Director	N/A	N/A	1970

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.

Corporate governance

Lucy Scientific Discovery Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.